A progressive stage IIIB melanoma treated with oncolytic ECHO-7 virus: A case report
Vladimirs Sorokins, Pēteris Alberts(Maxygen (United States)), Andra Tilgase, Agnija Rasa, Tatjana Zablocka(Riga East University Hospital), Sergejs Isajevs(Riga East University Hospital), Evija Olmane(Pauls Stradiņš Clinical University Hospital)
Cited by 5
Related Papers
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains
|Endocrinology|2003|263
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
|Diabetologia|2002|259
Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1
|Journal of Medicinal Chemistry|2002|211
The advent of oncolytic virotherapy in oncology: The Rigvir® story
|European Journal of Pharmacology|2018|179